The 8th edition of the American Joint Committee on Cancer has incorporated biomarkers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) into anatomic tumor-node-metastasis staging [14]. This evidence concerns the gene ERBB2 and neoplasm.